Lexicon Pharmaceuticals Inc [LXRX] stock prices are down -1.45% to $0.81 at the moment. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The LXRX shares have gain 14.92% over the last week, with a monthly amount drifted -25.66%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Lexicon Pharmaceuticals Inc [NASDAQ: LXRX] stock has seen the most recent analyst activity on June 17, 2024, when H.C. Wainwright initiated its Buy rating and assigned the stock a price target of $10. Previously, Leerink Partners started tracking the stock with Outperform rating on April 30, 2024, and set its price target to $5. On March 07, 2023, Jefferies initiated with a Hold rating and assigned a price target of $3 on the stock. Piper Sandler started tracking the stock assigning a Overweight rating and suggested a price target of $10 on August 12, 2022. JP Morgan upgraded its rating to a Neutral but $7 remained the price target by the analyst firm on January 29, 2021. Wedbush downgraded its rating to Neutral for this stock on January 29, 2021, and upped its price target to $8. In a note dated December 08, 2020, Citigroup upgraded an Buy rating on this stock.
The stock price of Lexicon Pharmaceuticals Inc [LXRX] has been fluctuating between $0.62 and $3.73 over the past year. Currently, Wall Street analysts expect the stock to reach $6 within the next 12 months. Lexicon Pharmaceuticals Inc [NASDAQ: LXRX] shares were valued at $0.81 at the most recent close of the market. An investor can expect a potential return of 640.74% based on the average LXRX price forecast.
Analyzing the LXRX fundamentals
The Lexicon Pharmaceuticals Inc [NASDAQ:LXRX] reported sales of 5.23M for trailing twelve months, representing a surge of 980.25%. Gross Profit Margin for this corporation currently stands at 0.88% with Operating Profit Margin at -40.37%, Pretax Profit Margin comes in at -41.09%, and Net Profit Margin reading is -41.09%. To continue investigating profitability, this company’s Return on Assets is posted at -0.67, Equity is -1.07 and Total Capital is -0.74. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.56.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.7622 points at the first support level, and at 0.7140 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.8463, and for the 2nd resistance point, it is at 0.8822.
Ratios To Look Out For
It’s worth pointing out that Lexicon Pharmaceuticals Inc [NASDAQ:LXRX]’s Current Ratio is 7.45. Also, the Quick Ratio is 7.43, while the Cash Ratio stands at 0.96. Considering the valuation of this stock, the price to sales ratio is 55.20, the price to book ratio is 1.64.
Transactions by insiders
Recent insider trading involved COATS LONNEL, Former Affiliate, that happened on Aug 15 ’24 when 0.3 million shares were purchased.
